Skip to content
Accessibility help
Search NICE…
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
BNF for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
In development
In development: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Deferred
Awaiting development
Topic prioritisation
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Expected publication date
Expected publication date
From date
To date
Apply date filters
Guidance programme
Guidance programme
Clinical guidelines (26)
Diagnostics guidance (2)
Early value assessment (8)
HealthTech guidance (39)
Highly specialised technologies guidance (5)
Interventional procedures guidance (13)
Late stage assessment (9)
Medical technologies guidance (2)
NICE guidelines (28)
Public health guidelines (1)
Technology appraisal guidance (294)
HealthTech approach
HealthTech approach
Early use (8)
Existing use (10)
Interventional procedure (13)
Routine use (7)
Area of interest
Area of interest
COVID-19 (6)
Apply filters
Showing 351 to 366 of 366
Sort by
Title
Date
Apply sorting
Type: Guidance
`Remove $Type: Guidance filter`
Guidance, NICE advice and quality standards in development
Title
Type
Expected publication date
Venetoclax with ibrutinib for treating relapsed mantle cell lymphoma [ID3879]
Technology appraisal guidance
TBC
Venous thromboembolism in over 16s : aspirin following orthopaedic surgery (update)
NICE guideline
TBC
Vepdegestrant for treating hormone receptor-positive HER2-negative metastatic breast cancer after endocrine treatment [ID6360]
Technology appraisal guidance
TBC
Vimseltinib for treating tenosynovial giant cell tumours when surgery is unsuitable [TSID12099]
Technology appraisal guidance
TBC
Vocimagene amiretrorepvec with extended-release 5-fluorocytosine for treating recurrent high-grade glioma [ID1425]
Technology appraisal guidance
TBC
Vosoritide for treating achondroplasia in people 4 months and over [ID6488]
Technology appraisal guidance
TBC
Waldenstrom's macroglobulinaemia - ibrutinib [ID884]
Technology appraisal guidance
22 November 2017
Women's and reproductive health guidelines
NICE guideline
TBC
Xanomeline tartrate–trospium chloride for treating schizophrenia ID6716
Technology appraisal guidance
TBC
Zanidatamab with chemotherapy with or without tislelizumab for untreated HER2-positive unresectable advanced gastro-oesophageal adenocarcinoma ID6672
Technology appraisal guidance
TBC
Zanubrutinib for untreated chronic lymphocytic leukaemia [ID5079]
Technology appraisal guidance
TBC
Zilucoplan for treating antibody positive generalised myasthenia gravis [ID4008]
Technology appraisal guidance
3 September 2026
Zio XT for detecting cardiac arrhythmias
HealthTech guidance
TBC
Zolbetuximab with nab-paclitaxel and gemcitabine for untreated claudin 18.2-positive metastatic pancreatic cancer [ID6444]
Technology appraisal guidance
TBC
Zongertinib for treating HER2-mutated unresectable or metastatic non-small-cell lung cancer ID6573
Technology appraisal guidance
TBC
Zuranolone for treating postnatal depression [ID6431]
Technology appraisal guidance
TBC
Previous page
1
…
6
7
Current page
8
Page
8
of
8
Results per page
10
25
50
All
Back to top